好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2017 Annual Meeting | C195 - Stroke Team Action Therapy (STAT): Current State of the Art and New Frontiers

Thursday 04/27/17
07:00 AM - 09:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Antonio Culebras, MD, FAHA, FAAN
Participants should become familiar with the expanding frontiers of mechanical thrombectomy in acute stroke and learn about the new guidelines for prevention of recurrent stroke in patients with PFO.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider
Case-based
Event Timeline
07:00 AM - 07:05 AM Luncheon Introduction
Antonio Culebras, MD, FAHA, FAAN
07:05 AM - 08:00 AM Speaker Frontiers of Mechanical Thrombectomy in Acute Stroke
Hesham Masoud, MD
08:00 AM - 09:00 AM Speaker Therapeutic Management of Recurrent Stroke in Patients with PFO and Additional Vascular Risk Factors
Steven R. Messe, MD, FAHA, FAAN
Faculty Disclosures
Steven R. Messe, MD, FAHA, FAAN Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Terumo. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WL Gore. The institution of Dr. Messe has received research support from WL Gore. The institution of Dr. Messe has received research support from Mallinkrodt. The institution of Dr. Messe has received research support from Biogen. Dr. Messe has received intellectual property interests from a discovery or technology relating to health care. Dr. Messe has received publishing royalties from a publication relating to health care. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving as a Clinical Event Committee for the CONFORMAL left atrial appendage occlusion trial with Yale Cardiovascular Research Group.
Antonio Culebras, MD, FAHA, FAAN Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for MEDLINK NEUROLOGY. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for MEDLINK NEUROLOGY. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Culebras has received publishing royalties from a publication relating to health care. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as a RESEARCH REVIEWER with DEPARTMENT OF DEFENSE. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as a REVIEWER with DOD.
Hesham Masoud, MD Dr. Masoud has nothing to disclose.